October 15, 2012 — Three-year data from the Zilver PTX randomized controlled trial of paclitaxel-eluting stents for ...
Peripheral Artery Disease (PAD)
This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.
October 11, 2012 — Spectranetics Corp. announced the U.S. market launch of the Tapas catheter at the 2012 Vascular ...
October 11, 2012
October 11, 2012 — Boston Scientific Corporation has begun the U.S. and European launch of its Victory guidewire ...
October 11, 2012
October 8, 2012 — Following Health Canada approval, Cook Medical made the Zilver Vena Venous Self-Expanding Stent availa ...
October 08, 2012
September 27, 2012 — Boston Scientific has launched the Promus Element Plus BTK (Below The Knee) everolimus-eluting ...
September 27, 2012
September 20, 2012 — Boston Scientific Corp. has signed a definitive agreement to acquire BridgePoint Medical Inc., a ...
September 20, 2012
September 18, 2012—Covidien announced the launch of the Viance Crossing Catheter and Enteer Re-entry System for treating ...
September 18, 2012August 30, 2012 — According to Millennium Research Group (MRG), an authority on the medical technology market, as ...
August 30, 2012
August 22, 2012 — Placement of an endovascular stent has become a common procedure for successfully reopening blocked ...
August 22, 2012
August 15, 2012 — Previously unreleased three-year data from the Zilver PTX randomized controlled trial of paclitaxel ...
August 15, 2012
Aug. 8, 2012 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s Omnilink Elite Vascular Balloon ...
August 08, 2012July 16, 2012 — Mercator MedSystems, a medical technology company whose platform Micro-Infusion Catheter technology ...
July 16, 2012July 13, 2012 — Angioslide Ltd., a provider of embolic capture angioplasty solutions, today announced the successful ...
July 13, 2012July 12, 2012 — Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation, a U.S ...
July 12, 2012July 9, 2012 — r4 Vascular Inc. announced clearance from the U.S. Food and Drug Administration (FDA) to market the ...
July 09, 2012